查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1421745

疫苗合约製造市场、份额、规模、趋势、行业分析报告：按疫苗类型、应用、工艺、地区和细分市场预测，2023-2032

Vaccine Contract Manufacturing Market Share, Size, Trends, Industry Analysis Report, By Vaccine Type ; By Application; By Process; By Region; Segment Forecast, 2023- 2032
出版日期: | 出版商: Polaris Market Research | 英文 119 Pages | 商品交期: 最快1-2个工作天内

价格

根据Polaris Market Research的最新研究，到2032年，全球疫苗合约製造市场预计将达到131.6亿美元。 该报告提供了对当前市场动态的详细见解，并对未来市场成长进行了分析。

製药和生物製药公司正在策略上优先考虑核心竞争力，以在日益激烈的价格竞争中生存。 因此，合约製造的趋势日益明显。

然而，疫苗生产给製造商带来了复杂的挑战，因为他们努力确保安全性、有效性和一致性。 疫苗合约製造市场由多种服务驱动，包括製造流程、製造设施建立和运作、细胞系开发、发酵、製程改进、分析表征等。 总的来说，这些服务在推动全球市场的显着成长方面发挥关键作用。

疫苗接种对于促进人畜健康有重要作用。 它不仅减少了对抗生素的依赖，而且对多种疾病起到了强有力的威慑作用。 现在人们认识到疫苗接种具有多种好处，例如预防严重疾病和传染病，并且疫苗接种工作和计划正在广泛倡导。 这导致大型製药公司意识到製造需要大量资金，因此选择在疫苗生产领域外包。

然而，资源匮乏国家缺乏疫苗生产设备和熟练劳动力，这是推动全球疫苗合约製造市场扩大的主要因素。 此外，EB66和GPEx等先进表达系统的引入以及创新的细胞培养基平台也极大地支持了市场的成长。 此外，各国COVID-19病例的快速增加促使疫苗开发公司与合约製造组织(CMO)签订外包协议，为市场发展创造了积极的轨迹。

疫苗合约製造市场报告亮点

由于效率高，灭活疫苗产业预计在预测期内复合年增长率最快。

2022年，兽医部门在收入中占据很大份额，这主要是由于在兽用疫苗生产中越来越多地使用CMO。

2022年，由于技术进步和创新，下游产业占据最大的市场份额。

2022年，由于技术的指数级增长和研发投资的增加，北美地区占据了最大的市场份额。

目录

第1章简介

第 2 章执行摘要

第3章研究方法

第 4 章全球疫苗合约製造市场洞察

  • 疫苗合约製造市场 - 流程快照
  • 疫苗合约製造市场动态
    • 推动者和机会
      • 疫苗需求的增加预计将刺激对该产品的需求
      • 生物製药领域的进展
    • 抑制因素和挑战
      • 复杂的监理环境
  • PESTEL 分析
  • 疫苗合约製造市场的製程趋势
  • 价值链分析
  • COVID-19 感染的影响分析

第5章全球疫苗合约製造市场(以疫苗类型)

  • 主要调查结果
  • 简介
  • 灭活□□疫苗
  • DNA疫苗
  • 减毒疫苗
  • 类毒素疫苗
  • 次单位疫苗

第6章全球疫苗合约製造市场，依应用划分

  • 主要调查结果
  • 简介
  • 人类
  • 动物

第7章全球疫苗合约製造市场(依流程)

  • 主要调查结果
  • 简介
  • 上游
  • 下游

第8章区域性全球疫苗合约製造市场

  • 主要调查结果
  • 简介
    • 2019-2032 年疫苗合约製造市场评估(按地区)
  • 疫苗合约製造市场 - 北美
    • 北美：2019-2032 年疫苗合约製造市场(以疫苗类型)
    • 北美：疫苗合约製造市场(依流程)，2019-2032 年
    • 北美：疫苗合约製造市场，按应用划分，2019-2032 年
    • 疫苗合约製造市场 - 美国
    • 疫苗合约製造市场 - 加拿大
  • 疫苗合约製造市场 - 欧洲
    • 欧洲：疫苗合约製造市场(以疫苗类型)，2019-2032 年
    • 欧洲：疫苗合约製造市场(依流程)，2019-2032 年
    • 欧洲：疫苗合约製造市场，依应用划分，2019-2032 年
    • 疫苗合约製造市场 - 英国
    • 疫苗合约製造市场 - 法国
    • 疫苗合约製造市场 - 德国
    • 疫苗合约製造市场 - 义大利
    • 疫苗合约製造市场 - 西班牙
    • 疫苗合约製造市场 - 荷兰
    • 疫苗合约製造市场 - 俄罗斯
  • 疫苗合约製造市场 - 亚太地区
    • 亚太地区：2019-2032 年疫苗合约製造市场(依疫苗类型)
    • 亚太地区：疫苗合约製造市场(依流程)，2019-2032 年
    • 亚太地区：疫苗合约製造市场，按应用划分，2019-2032 年
    • 疫苗合约製造市场 - 中国
    • 疫苗合约製造市场 - 印度
    • 疫苗合约製造市场 - 马来西亚
    • 疫苗合约製造市场 - 日本
    • 疫苗合约製造市场 - 印尼
    • 疫苗合约製造市场 - 韩国
  • 疫苗合约製造市场 - 中东/非洲
    • 中东和非洲：2019-2032 年疫苗合约製造市场(按疫苗类型)
    • 中东和非洲：疫苗合约製造市场(按流程)，2019-2032 年
    • 中东和非洲：疫苗合约製造市场，按应用划分，2019-2032 年
    • 疫苗合约製造市场 - 沙乌地阿拉伯
    • 疫苗合约製造市场 - 阿拉伯联合大公国
    • 疫苗合约製造市场 - 以色列
    • 疫苗合约製造市场 - 南非
  • 疫苗合约製造市场 - 拉丁美洲
    • 拉丁美洲：2019-2032 年疫苗合约製造市场(依疫苗类型)
    • 拉丁美洲：疫苗合约製造市场(按流程)，2019-2032 年
    • 拉丁美洲：疫苗合约製造市场，按应用划分，2019-2032 年
    • 疫苗合约製造市场 - 墨西哥
    • 疫苗合约製造市场 - 巴西
    • 疫苗合约製造市场 - 阿根廷

第9章竞争态势

  • 扩张与收购分析
    • 放大
    • 收购
  • 伙伴关係/协作/协议/揭露

第10章公司简介

  • AGC Biologics
  • Catalent, Inc.
  • Charles River Laboratories
  • Emergent BioSolutions
  • Fujifilm Diosynth Biotechnologies
  • IDT Biologika GmbH
  • KBI Biopharma
  • Lonza Group
  • Merck KGaA
  • Recipharm AB
  • Richter-Helm BioLogics GmbH & Co. KG
  • Seqirus(CSL Limited)
  • WuXi Biologics
  • Samsung Biologics
Product Code: PM4069

The global vaccine contract manufacturing market size is expected to reach USD 13.16 billion by 2032, according to a new study by Polaris Market Research. The report "Vaccine Contract Manufacturing Market Share, Size, Trends, Industry Analysis Report, By Vaccine Type (Inactivated Vaccine, DNA Vaccines, Attenuated Vaccine, Toxoid Vaccines, Subunit Vaccines); By Application; By Process; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Pharmaceutical and biopharmaceutical companies are strategically prioritizing their core competencies to navigate the escalating price pressures. Consequently, there is a growing inclination towards contract manufacturing.

However, vaccine production presents a complex challenge for manufacturers as they strive to guarantee safety, effectiveness, and consistency. The vaccine contract manufacturing market is driven by a diverse range of services encompassing production processes, the establishment and operation of manufacturing facilities, cell line development, fermentation, process refinement, and analytical characterization. These services collectively play a pivotal role in driving the market's substantial growth on a worldwide level.

Vaccination plays an important role in enhancing both human and veterinary health. It not only diminishes reliance on antibiotics but also serves as a potent deterrent against various diseases. The escalating recognition of its manifold advantages, which include safeguarding against severe illnesses and infectious conditions, is fueling the call for widespread immunization initiatives and inoculation programs. In tandem with this, the cognizance of the substantial capital outlay needed for production has prompted major pharmaceutical entities to opt for outsourcing in the realm of vaccine manufacturing.

However, in low-resource countries, the shortage of equipment and proficient labor for vaccine production is a significant factor driving the expansion of the global vaccine contract manufacturing market. Additionally, the introduction of advanced expression systems such as EB66 and GPEx, along with innovative cell culture media platforms, is providing substantial support for market growth. Furthermore, the surging instances of COVID-19 in various nations have prompted vaccine developers to engage in outsourcing agreements with Contract Manufacturing Organizations (CMOs), fostering a positive trajectory for market advancement.

Vaccine Contract Manufacturing Market Report Highlights

The Inactivated Vaccine segment is expected to witness the fastest CAGR during the forecast period on account of better efficiency.

The veterinary segment held a significant share in revenue share in 2022, which is mainly driven by increased utilization of CMOs in the production of animal vaccinations.

In 2022, the downstream segment held the largest market share due to technological advancements and innovation.

In 2022, the North American region held the largest market share, owing to exponential growth in technology and rising R&D investments.

The global key market players include: Fujifilm Diosynth Biotechnologies, IDT Biologika GmbH, KBI Biopharma, Lonza Group, Merck KGaA, and more.

Polaris Market Research has segmented the vaccine contract manufacturing market report based on vaccine type, application, process, and region:

Vaccine Contract Manufacturing, Vaccine Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Inactivated Vaccine
  • DNA Vaccines
  • Attenuated Vaccine
  • Toxoid Vaccines
  • Subunit Vaccines

Vaccine Contract Manufacturing, Application Outlook (Revenue - USD Billion, 2019 - 2032)

  • Human
  • Veterinary

Vaccine Contract Manufacturing, Process Outlook (Revenue - USD Billion, 2019 - 2032)

  • Upstream
  • Downstream

Vaccine Contract Manufacturing, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Vaccine Contract Manufacturing Market Insights

  • 4.1. Vaccine Contract Manufacturing Market - Process Snapshot
  • 4.2. Vaccine Contract Manufacturing Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increased demand for vaccines is projected to spur the product demand
      • 4.2.1.2. Biopharmaceutical Advancements
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Complex Regulatory Environment
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Vaccine Contract Manufacturing Market Process Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Vaccine Contract Manufacturing Market, by Vaccine Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • 5.3. Inactivated Vaccine
    • 5.3.1. Global Vaccine Contract Manufacturing Market, by Inactivated Vaccine, by Region, 2019-2032 (USD Billion)
  • 5.4. DNA Vaccines
    • 5.4.1. Global Vaccine Contract Manufacturing Market, by DNA Vaccines, by Region, 2019-2032 (USD Billion)
  • 5.5. Attenuated Vaccine
    • 5.5.1. Global Vaccine Contract Manufacturing Market, by Attenuated Vaccine, by Region, 2019-2032 (USD Billion)
  • 5.6. Toxoid Vaccines
    • 5.6.1. Global Vaccine Contract Manufacturing Market, by Toxoid Vaccines, by Region, 2019-2032 (USD Billion)
  • 5.7. Subunit Vaccines
    • 5.7.1. Global Vaccine Contract Manufacturing Market, by Subunit Vaccines, by Region, 2019-2032 (USD Billion)

6. Global Vaccine Contract Manufacturing Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • 6.3. Human
    • 6.3.1. Global Vaccine Contract Manufacturing Market, by Human, by Region, 2019-2032 (USD Billion)
  • 6.4. Veterinary
    • 6.4.1. Global Vaccine Contract Manufacturing Market, by Veterinary, by Region, 2019-2032 (USD Billion)

7. Global Vaccine Contract Manufacturing Market, by Process

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • 7.3. Upstream
    • 7.3.1. Global Vaccine Contract Manufacturing Market, by Upstream, By Region, 2019-2032 (USD Billion)
  • 7.4. Downstream
    • 7.4.1. Global Vaccine Contract Manufacturing Market, by Downstream, By Region, 2019-2032 (USD Billion)

8. Global Vaccine Contract Manufacturing Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Vaccine Contract Manufacturing Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Vaccine Contract Manufacturing Market - North America
    • 8.3.1. North America: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
    • 8.3.2. North America: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
    • 8.3.3. North America: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.3.4. Vaccine Contract Manufacturing Market - U.S.
      • 8.3.4.1. U.S.: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.3.5. Vaccine Contract Manufacturing Market - Canada
      • 8.3.5.1. Canada: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • 8.4. Vaccine Contract Manufacturing Market - Europe
    • 8.4.1. Europe: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.4.4. Vaccine Contract Manufacturing Market - UK
      • 8.4.4.1. UK: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.4.5. Vaccine Contract Manufacturing Market - France
      • 8.4.5.1. France: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.4.6. Vaccine Contract Manufacturing Market - Germany
      • 8.4.6.1. Germany: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.4.7. Vaccine Contract Manufacturing Market - Italy
      • 8.4.7.1. Italy: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.4.8. Vaccine Contract Manufacturing Market - Spain
      • 8.4.8.1. Spain: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.4.9. Vaccine Contract Manufacturing Market - Netherlands
      • 8.4.9.1. Netherlands: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.4.10. Vaccine Contract Manufacturing Market - Russia
      • 8.4.10.1. Russia: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • 8.5. Vaccine Contract Manufacturing Market - Asia Pacific
    • 8.5.1. Asia Pacific: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.5.4. Vaccine Contract Manufacturing Market - China
      • 8.5.4.1. China: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.5.5. Vaccine Contract Manufacturing Market - India
      • 8.5.5.1. India: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.5.6. Vaccine Contract Manufacturing Market - Malaysia
      • 8.5.6.1. Malaysia: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.5.7. Vaccine Contract Manufacturing Market - Japan
      • 8.5.7.1. Japan: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.5.8. Vaccine Contract Manufacturing Market - Indonesia
      • 8.5.8.1. Indonesia: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.5.9. Vaccine Contract Manufacturing Market - South Korea
      • 8.5.9.1. South Korea: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • 8.6. Vaccine Contract Manufacturing Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.6.4. Vaccine Contract Manufacturing Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.6.5. Vaccine Contract Manufacturing Market - UAE
      • 8.6.5.1. UAE: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.6.6. Vaccine Contract Manufacturing Market - Israel
      • 8.6.6.1. Israel: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.6.7. Vaccine Contract Manufacturing Market - South Africa
      • 8.6.7.1. South Africa: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • 8.7. Vaccine Contract Manufacturing Market - Latin America
    • 8.7.1. Latin America: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.7.4. Vaccine Contract Manufacturing Market - Mexico
      • 8.7.4.1. Mexico: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.7.5. Vaccine Contract Manufacturing Market - Brazil
      • 8.7.5.1. Brazil: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.7.6. Vaccine Contract Manufacturing Market - Argentina
      • 8.7.6.1. Argentina: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. AGC Biologics
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Catalent, Inc.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Charles River Laboratories
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Emergent BioSolutions
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Fujifilm Diosynth Biotechnologies
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. IDT Biologika GmbH
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. KBI Biopharma
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Lonza Group
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Merck KGaA
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Recipharm AB
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Richter-Helm BioLogics GmbH & Co. KG
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Seqirus (CSL Limited)
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. WuXi Biologics
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Samsung Biologics
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development

List of Tables

  • Table 1 Global Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 2 Global Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 3 Global Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 4 Vaccine Contract Manufacturing Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 6 North America: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 7 North America: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 8 U.S.: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 9 U.S.: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 10 U.S.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 11 Canada: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 12 Canada: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 13 Canada: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 14 Europe: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 15 Europe: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 16 Europe: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 17 UK: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 18 UK: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 19 UK: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 20 France: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 21 France: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 22 France: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 23 Germany: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 24 Germany: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 25 Germany: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 26 Italy: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 27 Italy: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 28 Italy: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 29 Spain: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 30 Spain: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 31 Spain: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 35 Russia: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 36 Russia: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 37 Russia: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 41 China: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 42 China: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 43 China: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 44 India: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 45 India: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 46 India: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 50 Japan: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 51 Japan: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 52 Japan: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 56 South Korea: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 57 South Korea: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 58 South Korea: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 65 UAE: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 66 UAE: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 67 UAE: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 68 Israel: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 69 Israel: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 70 Israel: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 71 South Africa: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 72 South Africa: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 73 South Africa: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 74 Latin America: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 75 Latin America: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 76 Latin America: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 77 Mexico: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 78 Mexico: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 79 Mexico: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 80 Brazil: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 81 Brazil: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 82 Brazil: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 83 Argentina: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 84 Argentina: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 85 Argentina: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Vaccine Contract Manufacturing Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Application
  • Figure 7. Global Vaccine Contract Manufacturing Market, by Application, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Vaccine Type
  • Figure 9. Global Vaccine Contract Manufacturing Market, by Vaccine Type, 2022 & 2032 (USD Billion)
  • Figure 10. Market by Process
  • Figure 11. Global Vaccine Contract Manufacturing Market, by Process, 2022 & 2032 (USD Billion)
  • Figure 12. Vaccine Contract Manufacturing Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Vaccine Contract Manufacturing Market